DocGo Inc. Amortization of Intangible Assets
DocGo Inc. (DCGO) reported Amortization of Intangible Assets of $62.04 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2026-08-17
- DocGo Inc. amortization of intangible assets for the quarter ending 2026-06-30 was $62.04K, a 95.73% decline year-over-year.
- DocGo Inc. amortization of intangible assets for the quarter ending 2026-03-31 was $21.04K, a 98.38% decline year-over-year.
- DocGo Inc. amortization of intangible assets for the quarter ending 2025-12-31 was $1.38M, a 78.06% increase year-over-year.
- DocGo Inc. amortization of intangible assets for the quarter ending 2025-09-30 was $1.45M, a 9.77% decline year-over-year.
- DocGo Inc. amortization of intangible assets for fiscal 2025 was $5.58M, a 1.38% decline from fiscal 2024.
- DocGo Inc. amortization of intangible assets for fiscal 2024 was $5.66M, a 7.84% increase from fiscal 2023.
- DocGo Inc. amortization of intangible assets for fiscal 2023 was $5.25M, a 63.29% increase from fiscal 2022.
- DocGo Inc. amortization of intangible assets for fiscal 2022 was $3.21M, a 74.23% increase from fiscal 2021.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $62.04K 10-Q · filed 2026-08-17 | $83.08K 10-Q · filed 2026-08-17 | $1.47M derived: sum of 3 quarters · filed 2026-08-17 | $2.91M derived: sum of 4 quarters · filed 2026-08-17 |
| 2026-03-31 | $21.04K 10-Q · filed 2026-05-11 | $1.40M derived: sum of 2 quarters · filed 2026-05-11 | $2.85M derived: sum of 3 quarters · filed 2026-05-11 | $4.30M derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-12-31 | $1.38M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $2.83M derived: sum of 2 quarters · filed 2026-03-16 | $4.28M derived: sum of 3 quarters · filed 2026-08-17 | $5.58M 10-K · filed 2026-03-16 |
| 2025-09-30 | $1.45M 10-Q · filed 2025-11-10 | $2.90M derived: sum of 2 quarters · filed 2026-08-17 | $4.20M 10-Q · filed 2025-11-10 | $4.98M derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-06-30 | $1.45M 10-Q · filed 2026-08-17 | $2.75M 10-Q · filed 2026-08-17 | $3.53M derived: sum of 3 quarters · filed 2026-08-17 | $5.13M derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-03-31 | $1.30M 10-Q · filed 2026-05-11 | $2.08M derived: sum of 2 quarters · filed 2026-05-11 | $3.68M derived: sum of 3 quarters · filed 2026-05-11 | $5.26M derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | $776.48K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $2.38M derived: sum of 2 quarters · filed 2026-03-16 | $3.97M derived: sum of 3 quarters · filed 2026-03-16 | $5.66M 10-K · filed 2026-03-16 |
| 2024-09-30 | $1.61M 10-Q · filed 2025-11-10 | $3.19M derived: sum of 2 quarters · filed 2025-11-10 | $4.88M 10-Q · filed 2025-11-10 | $5.84M derived: sum of 4 quarters · filed 2026-03-16 |
| 2024-06-30 | $1.58M 10-Q · filed 2025-08-07 | $3.28M 10-Q · filed 2025-08-07 | $4.23M derived: sum of 3 quarters · filed 2026-03-16 | $5.75M derived: sum of 4 quarters · filed 2026-03-16 |
| 2024-03-31 | $1.69M 10-Q · filed 2025-05-08 | $2.65M derived: sum of 2 quarters · filed 2026-03-16 | $4.16M derived: sum of 3 quarters · filed 2026-03-16 | $5.58M derived: sum of 4 quarters · filed 2026-03-16 |
| 2023-12-31 | $953.40K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $2.47M derived: sum of 2 quarters · filed 2026-03-16 | $3.88M derived: sum of 3 quarters · filed 2026-03-16 | $5.25M 10-K · filed 2026-03-16 |
| 2023-09-30 | $1.52M 10-Q · filed 2024-11-07 | $2.93M derived: sum of 2 quarters · filed 2024-11-07 | $4.30M 10-Q · filed 2024-11-07 | $5.24M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $1.41M 10-Q · filed 2024-08-07 | $2.78M 10-Q · filed 2024-08-07 | $3.73M derived: sum of 3 quarters · filed 2025-02-27 | $4.72M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $1.37M 10-Q · filed 2024-05-08 | $2.31M derived: sum of 2 quarters · filed 2025-02-27 | $3.30M derived: sum of 3 quarters · filed 2025-02-27 | $3.95M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $945.39K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $1.94M derived: sum of 2 quarters · filed 2025-02-27 | $2.58M derived: sum of 3 quarters · filed 2025-02-27 | $3.21M 10-K · filed 2025-02-27 |
| 2022-09-30 | $990.35K 10-Q · filed 2023-11-06 | $1.64M derived: sum of 2 quarters · filed 2023-11-06 | $2.27M 10-Q · filed 2023-11-06 | $2.68M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $645.72K 10-Q · filed 2023-08-08 | $1.28M 10-Q · filed 2023-08-08 | $1.69M derived: sum of 3 quarters · filed 2024-02-28 | $2.24M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $633.36K 10-Q · filed 2023-05-09 | $1.05M derived: sum of 2 quarters · filed 2024-02-28 | $1.60M derived: sum of 3 quarters · filed 2024-02-28 | $2.06M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $412.21K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $965.21K derived: sum of 2 quarters · filed 2024-02-28 | $1.42M derived: sum of 3 quarters · filed 2024-02-28 | $1.85M 10-K · filed 2024-02-28 |
| 2021-09-30 | $553.00K 10-Q · filed 2022-11-08 | $1.01M derived: sum of 2 quarters · filed 2022-11-08 | $1.43M 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $457.96K 10-Q · filed 2022-08-09 | $879.98K 10-Q · filed 2022-08-09 | ||
| 2021-03-31 | $422.02K 10-Q · filed 2022-05-10 | |||
| 2020-12-31 | $1.45M 10-K · filed 2022-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |